Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06387446 · ClinicalTrials.gov registry record · NA

Allogeneic Valve Transplantation

A NA study of Valve Disease, Heart and Valve Heart Disease, sponsored by Boston Children's Hospital.

Recruiting
Registry status
NA
Development phase
4
Enrollment target
1
Study location

NCT06387446: Recruiting NA study of Valve Disease, Heart and Valve Heart Disease, sponsored by Boston Children's Hospital.

NCT06387446 is a NA study of Valve Disease, Heart and Valve Heart Disease that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 4 participants, below the 731-participant average among 5 other Valve Disease, Heart trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06387446, a NA study of Valve Disease, Heart and Valve Heart Disease, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
NA
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

Valves will be taken from hearts donated by organ donors, and implanted into patients who need a new heart valve.

Primary Outcome

Heart valve regurgitation by echocardiogram. The degree of regurgitation is read and quantified by an echocardiologist.

Interventions

  • PROCEDURE Valve transplant

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2024-05-01
Est. Completion 2027-06-01
Phase NA
Boston Children's Hospital

462 total trials

What NCT06387446 shows while recruiting

NCT06387446 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 731-participant average among 5 other Valve Disease, Heart trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Valve Disease, Heart appearing as the primary indexed condition, and to 1 intervention - of which Valve transplant is the first listed.

NCT06387446 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06387446 about?

NCT06387446 is a clinical study titled "Allogeneic Valve Transplantation". Valves will be taken from hearts donated by organ donors, and implanted into patients who need a new heart valve.

What is the current status of trial NCT06387446?

This trial is currently recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2024-05-01. Estimated completion is 2027-06-01.

What conditions does trial NCT06387446 study?

This clinical trial studies the following conditions: Valve Disease, Heart, Valve Heart Disease, Valve Disease, Aortic.

What interventions are being tested in trial NCT06387446?

The interventions under investigation include: Valve transplant (PROCEDURE).

Who is sponsoring clinical trial NCT06387446?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06387446 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Valve Disease, Heart

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06387446, the US trial registry maintained by the National Library of Medicine. NCT06387446 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.